Twente Technology Fund

The Twente Technology Fund, established in 2010 and based in Enschede, Netherlands, is an independent venture capital fund dedicated to fostering high-tech entrepreneurial activities, particularly in the Twente region and at the University of Twente. The fund specializes in investing in seed and early-stage companies that are developing commercially viable products and technologies within sectors such as Clean Technology, Nanotechnology, Information Technology, Biomedical Technology, and Life Sciences. Additionally, it supports pre-seed academic projects with commercial potential. By focusing on these innovative areas, the Twente Technology Fund aims to capitalize on emerging technological developments and contribute to the region's economic growth.

Martijn Enter

Co-Founder and General Partner

2 past transactions

PhoeniX B.V.

Venture Round in 2015
PhoeniX Software supports organisations worldwide to improve quality, reduce time to market and enhance research by offering unique and highly integrated software solutions, training and customer support.

Encapson

Series A in 2012
Encapson is a Medical device technology company with the mission to improve patient comfort through innovation. They want to be at the forefront of a transition away from damaging imaging modalities like X-ray to cheaper and safer alternatives, with Ultrasound being the current focus. Their vision is to be the front-runner in echogenic coatings. They are working with medical device companies to improve ultrasound visibility on medical devices and in collaboration with our partners develop the gold standard for precision-guided medical procedures, to improve patient care and quality of life.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.